Memory CD4 T cell-mediated immunity against influenza a virus: More than a little helpful

Archivum Immunologiae et Therapiae Experimentalis

Volumn 61, Issue 5, 2013, Pages 341-353

  Kai McKinstry, K ^a   Dutton, Richard W ^a   Swain, Susan L ^a   Strutt, Tara M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Influenza vaccines; Memory T cells; Neutralizing antibodies

Indexed keywords

EPITOPE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR; VIRUS PROTEIN; VIRUS SIALIDASE;

ADOPTIVE TRANSFER; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN RECOGNITION; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE MODEL; EFFECTOR CELL; HETEROSUBTYPIC IMMUNITY; HOMOTYPIC IMMUNITY; HUMAN; HUMORAL IMMUNITY; IMMUNITY; IMMUNOMODULATION; INFECTION PREVENTION; INFLUENZA A; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; MEMORY T LYMPHOCYTE; NONHUMAN; PANDEMIC INFLUENZA; POINT MUTATION; REVIEW; SEASONAL INFLUENZA; TH1 CELL; VIRAL CLEARANCE; VIRUS IMMUNITY; VIRUS LOAD;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE INFECTIONS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84884671882     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-013-0236-z     Document Type: Review

References (113)

1. Amanna IJ, Slifka MK (2010) Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol Rev 236:125-138
2. Belser JA, Katz JM, Tumpey TM (2011) The ferret as a model organism to study influenza A virus infection. Dis Model Mech 4:575-579
3. Berkhoff EG, Geelhoed-Mieras MM, Jonges M et al (2007) An amino acid substitution in the influenza A virus hemagglutinin associated with escape from recognition by human virus-specific CD4+ T-cells. Virus Res 126:282-287
4. Bevan MJ (2011) Memory T cells as an occupying force. Eur J Immunol 41:1192-1195
5. Black S, Nicolay U, Vesikari T et al (2011) Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J 30:1081-1085
6. Bodewes R, Fraaij PL, Kreijtz JH et al (2012) Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine 30:7407-7410
7. Boonnak K, Subbarao K (2012) Memory CD4+ T cells: beyond "helper" functions. J Clin Invest 122:2768-2770
8. Bouvier NM, Lowen AC (2010) Animal models for influenza virus pathogenesis and transmission. Viruses 2:1530-1563
9. Boyden AW, Legge KL, Waldschmidt TJ (2012) Pulmonary infection with influenza A virus induces site-specific germinal center and T follicular helper cell responses. PLoS One 7:e40733
10. Brown DM, Dilzer AM, Meents DL et al (2006) CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J Immunol 177:2888-2898
11. Brown DM, Lee S, Garcia-Hernandez MD et al (2012) Multi-functional CD4 cells expressing IFN-gamma and perforin mediate protection against lethal influenza infection. J Virol 86:6792-6803
12. Chapman TJ, Topham DJ (2010) Identification of a unique population of tissue-memory CD4+ T cells in the airways after influenza infection that is dependent on the integrin VLA-1. J Immunol 184:3841-3849
13. Chapman TJ, Lambert K, Topham DJ (2011) Rapid reactivation of extralymphoid CD4 T cells during secondary infection. PLoS One 6:e20493
14. Chen GL, Lau YF, Lamirande EW et al (2011) Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine. Proc Natl Acad Sci USA 108:1140-1145
15. Clegg CH, Roque R, Van Hoeven N et al (2012) Adjuvant solution for pandemic influenza vaccine production. Proc Natl Acad Sci USA 109:17585-17590
16. Corti D, Voss J, Gamblin SJ et al (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333:850-856
17. Crotty S (2011) Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29:621-663
18. Crowe SR, Miller SC, Brown DM et al (2006) Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine 24:457-467
19. Damjanovic D, Divangahi M, Kugathasan K et al (2011) Negative regulation of lung inflammation and immunopathology by TNF-alpha during acute influenza infection. Am J Pathol 179:2963-2976
20. Dienz O, Rud JG, Eaton SM et al (2012) Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung. Mucosal Immunol 5:258-266
21. Dreyfus C, Laursen NS, Kwaks T et al (2012) Highly conserved protective epitopes on influenza B viruses. Science 337:1343-1348
22. Dutton RW, Bradley LM, Swain SL (1998) T cell memory. Annu Rev Immunol 16:201-223
23. Dutton RW, Swain SL, Woodland DL (2007) Vaccines against pandemic influenza. Viral Immunol 20:326-327
24. Eichelberger MC (2007) The cotton rat as a model to study influenza pathogenesis and immunity. Viral Immunol 20:243-249
25. Ekiert DC, Friesen RH, Bhabha G et al (2011) A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333:843-850
26. Elgueta R, de Vries VC, Noelle RJ (2010) The immortality of humoral immunity. Immunol Rev 236:139-150
27. Elsner RA, Ernst DN, Baumgarth N (2012) Single and coexpression of CXCR4 and CXCR5 identifies CD4 T helper cells in distinct lymph node niches during influenza virus infection. J Virol 86:7146-7157
28. Forrest BD, Pride MW, Dunning AJ et al (2008) Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin Vaccine Immunol 15:1042-1053
29. Francis T, Magill TP (1935) Immunological studies with the virus of influenza. J Exp Med 62:505-516
30. Galli G, Medini D, Borgogni E et al (2009) Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proc Natl Acad Sci USA 106:3877-3882
31. Ge X, Gebe JA, Bollyky PL et al (2010) Peptide-MHC cellular microarray with innovative data analysis system for simultaneously detecting multiple CD4 T-cell responses. PLoS One 5:e11355
32. Ge MQ, Ho AW, Tang Y et al (2012) NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-gamma and Perforin-dependent mechanisms. J Immunol 189:2099-2109
33. Hamada H, Bassity E, Flies A et al (2013) Multiple redundant effector mechanisms of CD8+ T cells protect against influenza infection. J Immunol 190:296-306
34. He XS, Holmes TH, Zhang C et al (2006) Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 80:11756-11766
35. Hessel L (2009) Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges. Influenza Respi Viruses 3:165-170
36. Hillaire ML, Osterhaus AD, Rimmelzwaan GF (2011) Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines. J Biomed Biotechnol 2011:939860
37. Hoft DF, Babusis E, Worku S et al (2011) Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children. J Infect Dis 204:845-853
38. Huang FF, Barnes PF, Feng Y et al (2011) GM-CSF in the lung protects against lethal influenza infection. Am J Respir Crit Care Med 184:259-268
39. Ishikawa H, Tanaka K, Kutsukake E et al (2010) IFN-gamma production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells. Virology 407:325-332
40. Kamperschroer C, Dibble JP, Meents DL et al (2006) SAP is required for Th cell function and for immunity to influenza. J Immunol 177:5317-5327
41. Kamperschroer C, Roberts DM, Zhang Y et al (2008) SAP enables T cells to help B cells by a mechanism distinct from Th cell programming or CD40 ligand regulation. J Immunol 181:3994-4003
42. Kirberg J, Baron A, Jakob S et al (1994) Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J Exp Med 180:25-34
43. Lambert ND, Ovsyannikova IG, Pankratz VS et al (2012) Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach. Expert Rev Vaccines 11:985-994
44. LaMere MW, Lam HT, Moquin A et al (2011) Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. J Immunol 186:4331-4339
45. Lau YF, Santos C, Torres-Velez FJ et al (2011) The magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokines. J Virol 85:76-85
46. Lee BO, Rangel-Moreno J, Moyron-Quiroz JE et al (2005) CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J Immunol 175:5827-5838
47. Liang S, Mozdzanowska K, Palladino G et al (1994) Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J Immunol 152:1653-1661
48. Lillie PJ, Berthoud TK, Powell TJ et al (2012) Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP + M1, in humans. Clin Infect Dis 55:19-25
49. London CA, Lodge MP, Abbas AK (2000) Functional responses and costimulator dependence of memory CD4+ T cells. J Immunol 164:265-272
50. Lowen AC, Mubareka S, Tumpey TM et al (2006) The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci USA 103:9988-9992
51. Luthje K, Kallies A, Shimohakamada Y et al (2012) The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nat Immunol 13:491-498
52. MacLeod MK, David A, McKee AS et al (2011) Memory CD4 T cells that express CXCR5 provide accelerated help to B cells. J Immunol 186:2889-2896
53. Malek TR (2008) The biology of interleukin-2. Annu Rev Immunol 26:453-479
54. McElhaney JE, Dutz JP (2008) Better influenza vaccines for older people: what will it take? J Infect Dis 198:632-634
55. McKinstry KK, Strutt TM, Buck A et al (2009) IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol 182:7353-7363
56. McKinstry KK, Strutt TM, Swain SL (2010a) The potential of CD4 T-cell memory. Immunology 130:1-9
57. McKinstry KK, Strutt TM, Swain SL (2010b) Regulation of CD4+ T-cell contraction during pathogen challenge. Immunol Rev 236:110-124
58. McKinstry KK, Strutt TM, Swain SL (2011) Hallmarks of CD4 T cell immunity against influenza. J Intern Med 269:507-518
59. McKinstry KK, Strutt TM, Kuang Y et al (2012) Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. J Clin Invest 122:2847-2856
60. Miotto HC, Couto BR, Goulart EM et al (2008) Advanced Cardiac Life Support Courses: live actors do not improve training results compared with conventional manikins. Resuscitation 76:244-248
61. Moris P, van der Most R, Leroux-Roels I et al (2011) H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses. J Clin Immunol 31:443-454
62. Nayak JL, Richards KA, Chaves FA et al (2010) Analyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins. Viral Immunol 23:169-180
63. O'Donnell CD, Subbarao K (2011) The contribution of animal models to the understanding of the host range and virulence of influenza A viruses. Microbes Infect 13:502-515
64. Palese P, Shaw ML (2007) Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields Virology. 5th edn. vol 2, Lippincott Williams & Wilkins, Philadelphia
65. Pedersen GK, Madhun AS, Breakwell L et al (2012) T-helper 1 cells elicited by H5N1 vaccination predict seroprotection. J Infect Dis 206:158-166
66. Perrone LA, Szretter KJ, Katz JM et al (2010) Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. J Infect Dis 202:1161-1170
67. Plotkin SA (2005) Vaccines: past, present and future. Nat Med 11(4 Suppl):S5-S11
68. Powell TJ, Strutt T, Reome J et al (2007) Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus. J Immunol 178:1030-1038
69. Price GE, Ou R, Jiang H et al (2000) Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia. J Exp Med 191:1853-1867
70. Price GE, Huang L, Ou R et al (2005) Perforin and Fas cytolytic pathways coordinately shape the selection and diversity of CD8+ T-cell escape variants of influenza virus. J Virol 79:8545-8559
71. Price GE, Soboleski MR, Lo CY et al (2010) Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses. PLoS One 5:e13162
72. Purwar R, Campbell J, Murphy G et al (2011) Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity. PLoS One 6:e16245
73. Richards KA, Chaves FA, Sant AJ (2011) The memory phase of the CD4 T-cell response to influenza virus infection maintains its diverse antigen specificity. Immunology 133:246-256
74. Richards KA, Chaves FA, Alam S et al (2012) Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins. Vaccine 31:219-225
75. Rimmelzwaan GF, Kuiken T, van Amerongen G et al (2003) A primate model to study the pathogenesis of influenza A (H5N1) virus infection. Avian Dis 47(3 Suppl):931-933
76. Roman E, Miller E, Harmsen A et al (2002) CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J Exp Med 196:957-968
77. Salomon R, Hoffmann E, Webster RG (2007) Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci USA 104:12479-12481
78. Scherle PA, Gerhard W (1986) Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. J Exp Med 164:1114-1128
79. Schotsaert M, Saelens X, Leroux-Roels G (2012) Influenza vaccines: T-cell responses deserve more attention. Expert Rev Vaccines 11:949-962
80. Schulman JL, Kilbourne ED (1965) Induction of partial specific heterotypic immunity in mice by a single infection with influenza a virus. J Bacteriol 89:170-174
81. Scott B, Liblau R, Degermann S, Marconi LA et al (1994) A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1:73-83
82. Seah SG, Carrington EM, Ng WC et al (2012) Unlike CD4 + T-cell help, CD28 costimulation is necessary for effective primary CD8+ T-cell influenza-specific immunity. Eur J Immunol 42:1744-1754
83. Seder RA, Ahmed R (2003) Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol 4:835-842
84. Seder RA, Darrah PA, Roederer M (2008) T-cell quality in memory and protection: implications for vaccine design. Nat Rev Immunol 8:247-258
85. Selin LK, Wlodarczyk MF, Kraft AR et al (2011) Heterologous immunity: immunopathology, autoimmunity and protection during viral infections. Autoimmunity 44:328-347
86. Sharma R, Sharma PR, Kim YC et al (2011) IL-2-controlled expression of multiple T cell trafficking genes and Th2 cytokines in the regulatory T cell-deficient scurfy mice: implication to multiorgan inflammation and control of skin and lung inflammation. J Immunol 186:1268-1278
87. Sheridan BS, Lefrancois L (2011) Regional and mucosal memory T cells. Nat Immunol 12:485-491
88. Song K, Bolton DL, Wei CJ et al (2010) Genetic immunization in the lung induces potent local and systemic immune responses. Proc Natl Acad Sci USA 107:22213-22218
89. Strutt TM, McKinstry KK, Dibble JP et al (2010) Memory CD4+ T cells induce innate responses independently of pathogen. Nat Med 16:558-564
90. Strutt TM, McKinstry KK, Swain SL (2011) Control of innate immunity by memory CD4 T cells. Adv Exp Med Biol 780:57-68
91. Strutt TM, McKinstry KK, Kuang Y et al (2012) Memory CD4+ T-cell-mediated protection depends on secondary effectors that are distinct from and superior to primary effectors. Proc Natl Acad Sci USA 109:E2551-E2560
92. Suguitan AL Jr, McAuliffe J, Mills KL et al (2006) Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med 3:e360
93. Sun J, Madan R, Karp CL et al (2009) Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 15:277-284
94. Sun K, Torres L, Metzger DW (2010) A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection. J Virol 84:5007-5014
95. Surls J, Nazarov-Stoica C, Kehl M et al (2012) Increased membrane cholesterol in lymphocytes diverts T-cells toward an inflammatory response. PLoS One 7:e38733
96. Swain SL, McKinstry KK, Strutt TM (2012) Expanding roles for CD4(+) T cells in immunity to viruses. Nat Rev Immunol 12:136-148
97. Tate MD, Deng YM, Jones JE et al (2009) Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J Immunol 183:7441-7450
98. Tate MD, Pickett DL, van Rooijen N et al (2010) Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J Virol 84:7569-7580
99. Tate MD, Schilter HC, Brooks AG et al (2011) Responses of mouse airway epithelial cells and alveolar macrophages to virulent and avirulent strains of influenza A virus. Viral Immunol 24:77-88
100. Taubenberger JK, Kash JC (2010) Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 7:440-451
101. Teijaro JR, Njau MN, Verhoeven D et al (2009) Costimulation modulation uncouples protection from immunopathology in memory T cell responses to influenza virus. J Immunol 182:6834-6843
102. Teijaro JR, Verhoeven D, Page CA et al (2010) Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms. J Virol 84:9217-9226
103. Teijaro JR, Turner D, Pham Q et al (2011) Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J Immunol 187:5510-5514
104. Thomas PG, Brown SA, Morris MY et al (2010) Physiological numbers of CD4 + T cells generate weak recall responses following influenza virus challenge. J Immunol 184:1721-1727
105. Treanor J (2004) Influenza vaccine - outmaneuvering antigenic shift and drift. N Engl J Med 350:218-220
106. Tripp RA, Sarawar SR, Doherty PC (1995) Characteristics of the influenza virus-specific CD8+ T cell response in mice homozygous for disruption of the H-2lAb gene. J Immunol 155:2955-2959
107. Waffarn EE, Baumgarth N (2011) Protective B cell responses to flu-no fluke! J Immunol 186:3823-3829
108. Wei CJ, Boyington JC, McTamney PM et al (2010) Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329:1060-1064
109. Weinfurter JT, Brunner K, Capuano SV 3rd et al (2011) Cross-reactive T cells are involved in rapid clearance of 2009 pandemic H1N1 influenza virus in nonhuman primates. PLoS Pathog 7:e1002381
110. Wilkinson TM, Li CK, Chui CS et al (2012) Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 18:274-280
111. Xu L, Yoon H, Zhao MQ et al (2004) Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells. J Immunol 173:721-725
112. Yewdell JW (2011) Viva la revolucion: rethinking influenza a virus antigenic drift. Curr Opin Virol 1:177-183
113. Yu X, Tsibane T, McGraw PA et al (2008) Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455:532-536